The invention provides compositions and methods for the treating disease using aptamers having 5'-5'and 3'-3' inverted nucleotide capped ends. In particular, the invention provides 5'-5' and 3'-3' capped and-VEGF aptamers of the treatment of neovascularization-related diseases and disorders including age-related macular degeneration.
申请公布号
WO2005014814(A2)
申请公布日期
2005.02.17
申请号
WO2004US25422
申请日期
2004.08.06
申请人
EYETECH PHARMACEUTICALS, INC.;ADAMIS, ANTHONY, P.;SHIMA, DAVID;WINCOTT, FRANCINE;CALIAS, PERRY
发明人
ADAMIS, ANTHONY, P.;SHIMA, DAVID;WINCOTT, FRANCINE;CALIAS, PERRY